Bruker (Nasdaq: BRKR) reported earnings on May 2. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), Bruker missed estimates on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue dropped. Non-GAAP earnings per share contracted significantly. GAAP earnings per share dropped significantly.

Margins contracted across the board.

Revenue details
 Bruker logged revenue of $393.4 million. The 12 analysts polled by S&P Capital IQ anticipated a top line of $416.8 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.08. The 12 earnings estimates compiled by S&P Capital IQ forecast $0.14 per share. Non-GAAP EPS of $0.08 for Q1 were 27% lower than the prior-year quarter's $0.11 per share. GAAP EPS of $0.03 for Q1 were 67% lower than the prior-year quarter's $0.09 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 44.4%, 250 basis points worse than the prior-year quarter. Operating margin was 3.1%, 560 basis points worse than the prior-year quarter. Net margin was 1.4%, 230 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $428.6 million. On the bottom line, the average EPS estimate is $0.16.

Next year's average estimate for revenue is $1.82 billion. The average EPS estimate is $0.81.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 251 members out of 267 rating the stock outperform, and 16 members rating it underperform. Among 46 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 44 give Bruker a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bruker is outperform, with an average price target of $20.50.

Looking for alternatives to Bruker? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.